RE:Very I last few weeks, monthsONC can say when the meeting date is Canaduh... it's 75 days from the date of receipt of the submission... it's very clear for Type C meeting... The meeting may not even be in person, FDA may just send responses to ONC... that's quite normal too. If FDA disagrees with the questions asked, then it's more likely that ONC will meet with them on the "meeting date".
Great that Roche is involved with Goblet... BUt you should also recall Matt Coffey on record as saying, Roche ONLY needed the Aware-1 data to pull the trigger...
He was careful enough not to say what pulling the trigger meant, but one would assume on a deal... and yet... of course he was also on record stating that Aware-1 would take a FEW months. The pps pumped in anticipation of news from this trial in early 2020... ONCY would have known that the trial was taking longer, but in their Dec 2019 slidedeck, they maintained their early Q1 data stance...
How's that for misleading investors?
You're right about finding a partner to run phase III or buy the company... Matt has just about run out of excuses on what direction mBC is heading.. The study protocol includes patient follow up to 2 years, and as per Clinical Trials.Gov, the trial completion date is July 2024. So, given the few patients still living, it should take no more than a few hours/days to complete the stats. I don't understand why ONC will wait till later in year to release results... or are they delaying because they still cannot find a partner.?
Every month is money burned... I want management to start providing some meat to the bones of this carcass. No more delays... a deal please Matt...